235 related articles for article (PubMed ID: 23690449)
1. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.
Johnsen JM; Auer PL; Morrison AC; Jiao S; Wei P; Haessler J; Fox K; McGee SR; Smith JD; Carlson CS; Smith N; Boerwinkle E; Kooperberg C; Nickerson DA; Rich SS; Green D; Peters U; Cushman M; Reiner AP;
Blood; 2013 Jul; 122(4):590-7. PubMed ID: 23690449
[TBL] [Abstract][Full Text] [Related]
2. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.
Tang W; Cushman M; Green D; Rich SS; Lange LA; Yang Q; Tracy RP; Tofler GH; Basu S; Wilson JG; Keating BJ; Weng LC; Taylor HA; Jacobs DR; Delaney JA; Palmer CD; Young T; Pankow JS; O'Donnell CJ; Smith NL; Reiner AP; Folsom AR
Am J Hematol; 2015 Jun; 90(6):534-40. PubMed ID: 25779970
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
4. A variational Bayes discrete mixture test for rare variant association.
Logsdon BA; Dai JY; Auer PL; Johnsen JM; Ganesh SK; Smith NL; Wilson JG; Tracy RP; Lange LA; Jiao S; Rich SS; Lettre G; Carlson CS; Jackson RD; O'Donnell CJ; Wurfel MM; Nickerson DA; Tang H; Reiner AP; Kooperberg C;
Genet Epidemiol; 2014 Jan; 38(1):21-30. PubMed ID: 24482836
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
[TBL] [Abstract][Full Text] [Related]
6. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
7. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.
Lapić I; Radić Antolic M; Boban A; Coen Herak D; Rogić D; Zadro R
Croat Med J; 2022 Apr; 63(2):166-175. PubMed ID: 35505650
[TBL] [Abstract][Full Text] [Related]
9. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.
Campos M; Buchanan A; Yu F; Barbalic M; Xiao Y; Chambless LE; Wu KK; Folsom AR; Boerwinkle E; Dong JF
Blood; 2012 Feb; 119(8):1929-34. PubMed ID: 22219226
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing of 14 389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors.
Pankratz N; Wei P; Brody JA; Chen MH; de Vries PS; Huffman JE; Stimson MR; Auer PL; Boerwinkle E; Cushman M; de Maat MPM; Folsom AR; Franco OH; Gibbs RA; Haagenson KK; Hofman A; Johnsen JM; Kovar CL; Kraaij R; McKnight B; Metcalf GA; Muzny D; Psaty BM; Tang W; Uitterlinden AG; van Rooij JGJ; Dehghan A; O'Donnell CJ; Reiner AP; Morrison AC; Smith NL
Hum Mol Genet; 2022 Sep; 31(18):3120-3132. PubMed ID: 35552711
[TBL] [Abstract][Full Text] [Related]
11. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
[TBL] [Abstract][Full Text] [Related]
12. Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans.
Raffield LM; Lu AT; Szeto MD; Little A; Grinde KE; Shaw J; Auer PL; Cushman M; Horvath S; Irvin MR; Lange EM; Lange LA; Nickerson DA; Thornton TA; Wilson JG; Wheeler MM; ; Zakai NA; Reiner AP
J Thromb Haemost; 2020 Jun; 18(6):1335-1347. PubMed ID: 31985870
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.
Casonato A; Pontara E; Zerbinati P; Zucchetto A; Girolami A
Am J Clin Pathol; 1998 Mar; 109(3):347-52. PubMed ID: 9495210
[TBL] [Abstract][Full Text] [Related]
14. Type 2N von Willebrand disease: Characterization and diagnostic difficulties.
Casonato A; Galletta E; Sarolo L; Daidone V
Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006
[TBL] [Abstract][Full Text] [Related]
15. VWF sequence variants: a data goldmine.
Goodeve AC
Blood; 2013 Jul; 122(4):471-3. PubMed ID: 23886775
[No Abstract] [Full Text] [Related]
16. Reevaluation of von Willebrand disease diagnosis in a Croatian paediatric cohort combining bleeding scores, phenotypic laboratory assays and next generation sequencing: a pilot study.
Lapić I; Radić Antolic M; Dejanović Bekić S; Coen-Herak D; Bilić E; Rogić D; Zadro R
Biochem Med (Zagreb); 2022 Feb; 32(1):010707. PubMed ID: 35210927
[TBL] [Abstract][Full Text] [Related]
17. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study.
Bugnicourt JM; Roussel B; Tramier B; Lamy C; Godefroy O
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):699-701. PubMed ID: 17189302
[TBL] [Abstract][Full Text] [Related]
18. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
19. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A
Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577
[TBL] [Abstract][Full Text] [Related]
20. Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes.
Wang QY; Song J; Gibbs RA; Boerwinkle E; Dong JF; Yu FL
J Thromb Haemost; 2013 Feb; 11(2):261-9. PubMed ID: 23216583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
